Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 7 (MTND2P7) is a non-protein-coding pseudogene classified by the HUGO Gene Nomenclature Committee as a pseudogene variant related to the mitochondrial gene MT-ND2. MT-ND2 itself is a functional mitochondrial gene that encodes a core subunit (ND2) of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial respiratory chain, which is involved in oxidative phosphorylation and cellular respiration. However, as a pseudogene, MTND2P7 does not encode a functional protein, and there is no evidence that it has an active biological or pathological role. It is not considered a receptor, enzyme, transporter, or any other canonical drug target class. No aliases beyond formal synonyms are in use, and this locus is not associated with direct disease risk or drug targeting. Pseudogenes are DNA sequences similar to functional genes but have lost their protein-coding ability or are otherwise nonfunctional due to mutations or lack of regulatory elements. While some mitochondrial pseudogenes may be differentially expressed in tissues or in certain diseases, including Alzheimer's disease (AD), there is no compelling evidence that MTND2P7 itself is functionally implicated. Most biomedical databases and gene nomenclature resources list MTND2P7 simply as a pseudogene and do not provide further structural, functional, or clinical relevance. The functional MT-ND2 gene is distinct: it is part of Complex I; its mutations cause several mitochondrial disorders, but this does not apply to the pseudogene. There is no indication that MT-ND2 pseudogene 7 is a valid therapeutic target or plays a recognized biological role in human disease or pharmacology. Any references suggesting functional or disease relevance for MT-ND2 should be carefully cross-checked to ensure they do not pertain to the actual functional gene, MT-ND2, rather than this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 7 (MTND2P7).